Search / 53 results found Showing: 1-10 of 53
FILE - A healthcare worker fills a syringe with the Pfizer COVID-19 vaccine at Jackson Memorial Hospital on Oct. 5, 2021, in Miami. U.S. regul…
NEW YORK (AP) — An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday,…
LONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 …
(JTA) — Israel’s government reached an agreement with the pharmaceutical company Pfizer to purchase tens of thousands of doses of the company’…
It’s the brand name Pfizer/BioNTech chose to call their vaccine. It’s the exact same vaccine, it just has a new name.
Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 in what would be a major expansion tha…
Published in the “New England Journal of Medicine,” the researchers found a significant waning of immune responses—especially among men, people over 65 and immunosuppressed people.
The post Israeli study: Pfizer vaccine wears off after six months appeared first on JNS.org.
Before authorizing a third COVID-19 vaccine shot for all, the U.S. is looking to clarify the risk of myocarditis mRNA vaccines pose to young people.
The post US to examine Israeli data on booster-shot side effects in young people appeared first on JNS.org.
WASHINGTON (AP) – An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.
Israeli Health Ministry data on Wednesday showed that per 100,000 people, there are 172 serious cases from unvaccinated people over 60 compared to 21 serious cases from the vaccinated.
The post Third Pfizer vaccine shot 86 percent effective for those over 60, Israeli healthcare provider said appeared first on JNS.org.
